Hepatitis A virus (HAV) is a non-enveloped, positive-stranded RNA virus belonging to the genus Hepatovirus in the family Picornaviridae . It poses a significant public health threat, causing acute liver disease known as hepatitis A. The HAV genome consists of a large open reading frame, which includes the P1, P2, and P3 regions . The P2 and P3 regions encode non-structural proteins essential for viral replication and assembly.
The P2C protein is a putative NTPase, which plays a pivotal role in viral replication . It is involved in membrane association and RNA binding, crucial for the replication process. The P3A protein, on the other hand, is involved in the assembly and release of the virus. Together, these proteins are essential for the life cycle of HAV.
Recombinant HAV P2C-P3A is a synthetic construct that combines the P2C and P3A proteins. This recombinant protein is used in various research and diagnostic applications. It is manufactured with high sensitivity, specificity, and reproducibility, making it ideal for use in immunization protocols and generating antibodies that specifically target the protein of interest .
The recombinant HAV P2C-P3A protein is widely used in research to study the mechanisms of HAV replication and assembly. It is also used in the development of diagnostic assays and vaccines. The high specificity and sensitivity of this recombinant protein make it a valuable tool in the field of virology and immunology.